COST vs PRLD · P/E 55, rev $275.24B vs rev $6.5M
Costco Wholesale Corp (COST) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. Revenue was up 8.2% from 2024-09-01 to 2025-08-31. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
COST currently screens at market cap $430.32B and trailing P/E 54.9. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the COST and PRLD stock pages for the full models.
Not investment advice.